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Abstract
Background: Human endogenous retroviruses (HERVs) constitute 8% of the human genome and contribute
substantially to the transcriptome. HERVs have been shown to generate RNAs that modulate host gene
expression. However, experimental evidence for an impact of these regulatory transcripts on the cellular
phenotype has been lacking.
Results: We characterized the previously little described HERV-K(HML-10) endogenous retrovirus family on a
genome-wide scale. HML-10 invaded the ancestral genome of Old World monkeys about 35 Million years
ago and is enriched within introns of human genes when compared to other HERV families. We show that
long terminal repeats (LTRs) of HML-10 exhibit variable promoter activity in human cancer cell lines. One
identified HML-10 LTR-primed RNA was in opposite orientation to the pro-apoptotic Death-associated protein 3 (DAP3).
In HeLa cells, experimental inactivation of HML-10 LTR-primed transcripts induced DAP3 expression levels, which led to
apoptosis.
Conclusions: Its enrichment within introns suggests that HML-10 may have been evolutionary co-opted for
gene regulation more than other HERV families. We demonstrated such a regulatory activity for an HML-10
RNA that suppressed DAP3-mediated apoptosis in HeLa cells. Since HML-10 RNA appears to be upregulated
in various tumor cell lines and primary tumor samples, it may contribute to evasion of apoptosis in malignant
cells. However, the overall weak expression of HML-10 transcripts described here raises the question whether
our result described for HeLa represent a rare event in cancer. A possible function in other cells or tissues
requires further investigation.
Keywords: Apoptosis, Cancer, DAP3, Death-associated protein 3, Endogenous retrovirus, Gene regulation,
Genome evolution, HERV, HERV-K(HML-10)
Background
About half of the human genome is composed of trans-
posable elements (TEs) [1], and recent evidence suggests
even a fraction of up to two thirds [2]. The most abun-
dant TEs in the human genome are retroelements (REs)
that amplify via a ‘copy-and-paste’ mechanism involving
reverse transcription of an RNA intermediate [1, 3].
One class of REs, HERVs, comprises remnants of ancient
retroviral germ line cell infections that became evolutionary
fixed in the genome. About 450,000 HERV elements consti-
tute 8% of the human genome and are classified into about
30 families [1, 4]. HERVs are structurally similar to provi-
ruses of present-day retroviruses where the gag, pol and env
genes are flanked by two long terminal repeats (LTRs) that
act as promoters [4]. HERVs and other REs have been
shown to influence gene regulation by providing regulatory
elements such as enhancers, promoters, splice- and polya-
denylation sites, for various host genes [3]. REs of all classes
often contain functional promoters and consequently
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contribute to a large fraction of the human transcriptome
[5]. Numerous REs are located within introns of host genes
and might be involved in antisense gene regulation in cis
[1]. The potential significance of RE-mediated cis-antisense
gene regulation is suggested by the genome-wide presence
of about 48,000 transcription start sites (TSSs) within
HERVs and other REs that are in reverse orientation to
overlapping host genes [6].
Promoter activity, a prerequisite for REs to exert
antisense-mediated gene regulation, has been shown for
representative LTRs of HERV-E [7], HERV-W [8], HERV-H
[9–12], HERV-L [9], HERV-I [13] and HERV-K(HML-2),
HML standing for human mouse mammary tumor virus-
like [14–17]. The latter HERV family, HML-2 in the follow-
ing, is the phylogenetically most recent and most active one
in the human genome [3, 4], with about 50% of LTRs being
transcriptionally active [15]. Antisense gene regulation in
cis has been shown for HML-2 LTRs located within introns
of the SLC4A8 (a sodium bicarbonate co-transporter) and
IFT172 (intraflagellar transport protein 172) genes [14]. In
addition, the PLA2G4A gene that encodes a phospholipase
with a possible implication in tumorigenesis is negatively
regulated by a HERV-E LTR-primed transcript [7]. These
three individual cases are presently the only experimentally
verified examples of the influence of LTR-primed tran-
scripts on gene regulation.
A HERV family phylogenetically related to HML-2 is
HERV-K(HML-10), HML-10 in the following [4]. The proto-
typical HML-10 provirus located within an intron of the long
variant of the Complement Component 4 (C4) gene has been
shown to possess promoter activity in its 3′LTR [18, 19].
Since this provirus remains the only one studied in detail to
date, we here characterized the HML-10 family in more
detail. We found that HML-10 invaded the ancestral genome
of the Old World monkey (OWM) lineage about 35 Mya. A
survey of the human genome revealed that HML-10 se-
quences were significantly enriched within host gene introns,
indicating their evolutionary recruitment for gene regulatory
functions. Three intron-located HML-10 proviruses exerted
LTR promoter activity in the human HEK293T and HepG2
tumor cell lines in vitro. Transcriptional orientation and
strength varied substantially between the cell lines and pro-
moter activity was suppressed by interferon-gamma (IFNγ).
One of the proviral LTRs showed transcriptional activity in
opposite orientation to the encompassing pro-apoptotic
DAP3 gene that encodes a signaling protein of the Death
Receptor (DR) pathway [20, 21]. We provide evidence that
HML-10 LTR-primed transcripts negatively regulate DAP3
expression in HeLa cells, as their inactivation by antisense
oligonucleotides (ASOs) led to a 10-fold increase in DAP3
mRNA levels and efficiently promoted apoptosis. Our
findings support the functional relevance of LTR-primed cis-
regulatory transcripts for human gene regulation and the
cellular phenotype and function.
Results
HML-10 elements are 35 million years old and enriched
within human genes
To identify potential priming of cis-acting regulatory tran-
scripts by HERVs, we mined the GRCh38/hg38 human
genome assembly [1] for sequences of the previously little
described HML-10 family. The prototype member of
HML-10 is an intron-located provirus in the long form of
the C4 gene that exhibits LTR promoter activity in vitro
[18, 19]. Expression of this provirus has been detected via
microarray before, for instance, in brain, breast, kidney
and skin tissue, blood cells as well as various human
cancer cell lines [22–27].
The provirus inside of the C4 gene is currently the only
HML-10 sequence described in the literature [18, 19]. With
a size of about 6400 basepairs (bp) it contains the retroviral
gag, pol and env genes, an A/T-rich stretch of unknown
function between pol and env and two flanking LTRs [18]
(Fig. 1a). Most HERV elements found in the human
genome today have undergone homologous recombination
between their two proviral LTRs, leaving behind solitary
LTRs [1, 3, 4] that in this case have a size of about 550 bp.
We identified seventy HML-10 elements within the human
genome (Table 1). Of these, seven are proviruses with the
structure 5′LTR-gag-pol-A/T-rich-env-3′LTR (with element
no. 58 lacking the 5′LTR) and 63 are solitary LTRs. Some
of the elements are truncated at either end or harbor other
REs, mostly Alus. HERV sequences can be amplified by
chromosomal duplication events following integration [4].
To reveal whether the identified HML-10 elements repre-
sent independent integration events, we determined their
target site duplications (TSDs). The TSDs were expected to
differ between independently acquired HML-10 elements.
It has been shown previously that the provirus in the C4
gene (element no. 22) created a 6 bp TSD [18]. Confirming
these findings, we could identify TSDs of 5 or 6 bp for most
(59 of 70) HML-10 elements (Table 1). All identified TSDs
had a unique sequence, whereby the two copies of element
no. 22 showed an identical 6 bp TSD with the expected
sequence [18]. Alignment of the flanking regions of each
HML-10 element (±1000 bp) revealed no sequence
homology except for the two proviruses of element
no. 22 as well as between elements nos. 27 and 45
(Additional file 1: Figure S1). Thus, one of the latter
two has arisen through chromosomal duplication and
the other 69 HML-10 elements listed in Table 1 are
likely the result of independent retroviral integration
events.
To reveal the evolutionary history of HML-10, we first
searched for HML-10 sequences in genomes of different
mammalian species. HML-10 was identified in all investi-
gated genomes of the OWM lineage, but was absent in the
genomes of New World monkeys (NWMs) and the more
distantly related species mouse lemur, bushbaby and mouse
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(Fig. 1b). The OWM genomes contained between 80 and
96 HML-10 sequences (Additional file 2: Table S1). Of note,
about 600 sequences annotated as HML-10 by RepeatMas-
ker were found in the investigated NWM genomes that
however shared little sequence homology with the ones
found in OWMs. Thus, the annotated HML-10 elements
in OWM and NWM genomes likely represent two distinct
HERV families.
The evolutionary age of HML-10 was estimated by cal-
culating the nucleotide sequence divergence between
both LTRs of each of the six complete proviruses
(Table 1), applying a mutation rate of 2.28 substitutions
per site and year × 10−9 as described [28]. This analysis
yielded an evolutionary age of 35.3 ± 7.8 million years
(mean ± SD, see box-and-whiskers plot in Fig. 1b).
Phylogenetic neighbor-joining analysis of 68 complete
human HML-10 LTRs, including both LTRs of each of six
complete proviruses, revealed a near-monophyletic tree
(Fig. 2), indicating a single integration period. Therefore,
the infectious progenitor of HML-10 likely invaded the
ancestral genomes of OWM during a brief period around
35 Mya (Fig. 1b). The same age has been attributed before
to other endogenous human betaretrovirus families, in-
cluding HML-2 [4], HML-3 [29], HML-4 [30] and HML-6
[31]. In contrast, the HML-5 infectious progenitor was
active about 55 Mya [32] and HML-2 has remained active
after the divergence of humans and chimpanzees about six
Mya [4]. Neighbor-joining analysis of pol sequences of vari-
ous endogenous and exogenous betaretroviruses showed
that HML-10 is closely related to HML-1 through HML-9
HERVs and the extant exogenous retroviruses JSRV (Jaag-
siekte sheep retrovirus), MPMV (Mason-Pfizer monkey
virus) and MMTV (mouse mammary tumor virus) (Fig. 1c).
HML-10 elements are non-randomly distributed among
human chromosomes (Fig. 1d). Most notably, the relatively
small chromosome 19 harbored the highest number of ele-
ments (11 of 70). This was a first indication that HML-10
sequences were preferentially located near host genes, since
chromosome 19 is the most gene-dense one [1]. Of the 70
HML-10 elements, 29 (41.4%) were found within introns of
human genes (as annotated by RefSeq [33]), and 16 of the
remaining 41 intergenic elements were located in proximity
(±10,000 bp) to at least one RefSeq gene (Table 1). The
relatively frequent location of HML-10 in the vicinity of
host genes is a feature that is not shared with other HERV
families studied in this regard. Namely, only 28% of all
HERV-W elements are located within introns of genes [8]
and HML-2 was found to be enriched outside genes,
although de novo infection and integration of a resurrected
HML-2 retrovirus favored actively transcribed regions [34],
a b c
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Fig. 1 Characteristics of the HML-10 endogenous retrovirus family. a Structure of HML-10 proviruses [18]. b Estimation of the evolutionary age of
HML-10 with divergence times as reported before [78]. The box-and-whiskers plot shows age estimation by sequence comparison of LTRs from six
complete proviruses (elements nos. 1, 3, 20, 22, 25 and 68 in Table 1) in the human genome [28]. The arrowhead indicates the integration events
in the OWM lineage. c Neighbor-joining tree of Pol protein sequences of different endogenous and exogenous betaretroviruses [18, 72].
The horizontal bar represents 0.1 substitutions per amino acid position. d Chromosomal distribution of HML-10 elements in the human
genome. Details can be found in Table 1. e Comparison of genomic fractions of intragenic elements (located within the boundaries of
RefSeq [33] genes) between HML-10 and other HERV families in the human genome. All observed distributions differed significantly from
the expected value for random integration that is shown as dotted horizontal line, with P-values ≤ 0.01 inferred by chi-square tests
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Table 1 HML-10 elements in the human genome




1 1p36.13 chr1:19926886-19932710 (-) Provirus WWAAAT - Intergenic - PLA2G2E
2 1p35.3 chr1:29156730-29157306 (-) LTR GTTAC - Intronic SFRS4 (s) -
3 1q22 chr1:155691832-155699521 (-) Provirus ATTAAG AluSp; MER11B Intronic DAP3 (as) YY1AP1
4 1q23.1 chr1:158534566-158535143 (+) LTR GTCCAA - Intergenic - -
5 1q32.3 chr1:213045116-213046160 (-) LTRa TAGTGG - Intergenic - RPS6KC1
6 2p11.2 chr2:86245199-86245755 (+) LTR TATAC - Intronic REEP1 (as) -
7 2q37.3 chr2:238659222-238659778 (+) LTR not found - Intergenic - -
8 2q37.3 chr2:240556198-240556747 (+) LTR not found - Intronic ANKMY1 (as) DUSP28
9 3p14.2 chr3:58724279-58724839 (+) LTR CAGCAG - Intergenic - -
10 3q12.2 chr3:101089113-101089658 (+) LTR AGGCAC - Intergenic - -
11 3q21.3 chr3:128828801-128835173 (+) LTR TGCAT AluY; LTR7B;
HERVH
Intergenic - -
12 3q24 chr3:146283898-146284161 (-) LTRb not found - Intergenic - -
13 4p16.3 chr4:1709255-1710065 (+) LTR ATGGGG AluY Intronic SLBP (as) TMEM129
14 4p16.1 chr4:8441728-8442282 (-) LTR YYTTTA - Intronic TRMT (as) ACOX3
15 4q31.21 chr4:143777776-143778330 (+) LTR TCARCC - Intergenic - -
16 5q14.1 chr5:78245022-78245575 (-) LTR TCYWCA - Intronic AP3B1 (s) -
17 5q14.1 chr5:78248004-78248093 (-) LTRb not found - Intronic AP3B1 (s) -
18 5q31.3 chr5:142088759-142089306 (-) LTR TTGGTG - Intergenic – -
19 6p24.1 chr6:12989575-12990131 (-) LTR GAAAAC - Intronic PHACTR1 (as) -
20 6p22.1 chr6:27187520-27196279 (+) Provirus AAGATM 3× AluY;
AluYc; LTR13A
Intergenic - -
21 6p22.1 chr6:28607908-28608446 (+) LTR CATGTT - Intergenic - -




- Intronic C4A/C4B (as) CYP21A1P;
STK19; TNXB
23 6p21.32 chr6:32512829-32513385 (+) LTR GGGGRG - Intergenic - HLA-DRB5
24 6q21 chr6:114011436-114018365 (+) LTR CCCTAT LTR7B; HERVH Intergenic - -
25 6q22.31 chr6:122504844-122512093 (-) Provirus GGACAT 3× AluY Intronic PKIB (as) -
26 7q36.2 chr7:154936774-154937317 (-) LTR ACTCCA - Intronic PAXIP1 (as) PAXIP1-AS2
27 8p22 chr8:17915846-17916036 (-) LTRb CCCMTA - Intergenic - PCM1
28 8p21.3 chr8:22985089-22985644 (-) LTR CCTCYY - Intergenic - RHOBTB2
29 8q11.1 chr8:46533684-46534254 (+) LTR CATTTC - Intergenic - -
30 8q21.13 chr8:82206225-82206776 (+) LTR CASCCK - Intergenic - -
31 9p13.3 chr9:34539821-34540365 (-) LTR GGCATG - Intergenic - -
32 9q22.1 chr9:87984145-87984721 (-) LTR TATGGC - Intergenic - CDK20
33 9q22.31 chr9:92523403-92523958 (-) LTR WATTGT - Intronic CENPP (as); ECM2 (s) -
34 9q31.3 chr9:109072071-109072632 (+) LTR CMAAAG - Intronic TMEM245 (as) -
35 9q34.11 chr9:129101280-129101834 (+) LTR GGGGAA - Intronic CRAT (as) PPP2R4
36 9q34.13 chr9:132289026-132289571 (+) LTR CTCTYA - Intronic SETX (as) -
37 10p11.21 chr10:37685164-37685717 (+) LTR GAATC - Intergenic - -
38 11p11.2 chr11:43747422-43747974 (+) LTR GTTCTG - Intronic HSD17B12 (s) -
39 12p13.1 chr12:12810288-12810845 (-) LTR ATCTA - Intergenic - DDX47
40 12q24.33 chr12:132949015-132949570 (+) LTR GTATC - Intronic ZNF605 (as) -
41 13q13.3 chr13:37090225-37090778 (+) LTR CCTGTT - Intergenic - -
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a common feature of present-day retroviruses as well [35].
Based on the published literature about HERV-W and
HML-2, we compared the integration preferences of these
two HERV families with HML-10 as well as all other HML
families, except for HML-9 that was not annotated by
RepeatMasker, at the genome-wide level. HML-10 se-
quences were found with higher frequency within the
boundaries of RefSeq genes (47.94%) than expected by ran-
dom distribution (44.79%), whereby sequences of HML-2
(28.76%), HERV-W (27.95%) and of all annotated HERV el-
ements combined (28.46%) were less abundant within
genes (Fig. 1e). The intragenic sequence fractions of the
other HML families were below the expected value for ran-
dom integration and ranged between 24.35% (HML-1) and
36.75% (HML-4). Thus, the frequent location of HML-10
within host genes appears to be a unique feature of this
family and suggests an important and conserved function
for gene regulation. The intronic HML-10 elements showed
a distinct bias for integration in reverse orientation relative
to the respective encompassing gene, with 20 being in re-
verse (antisense) and 7 in parallel (sense) orientation
(Table 1). Two elements were reverse to one gene and par-
allel to another overlapping one. The integration bias of
HML-10 indicates that the reverse orientation was evolu-
tionarily favored, which is in line with previous findings of
other HERV families [36–38]. One explanation for this ob-
servation is that parallel intronic proviruses are more
likely to disrupt the encompassing gene due to the pres-
ence of transcription termination sites in the LTRs, which
leads to negative selection of such integration events [39].
Table 1 HML-10 elements in the human genome (Continued)
42 14q31.1 chr14:79706443-79707024 (+) LTR TTGGTC - Intronic NRXN3 (s) -
43 16p13.13 chr16:10785748-10785943 (+) LTRb not found - Intronic FAM18A (as) -
44 16p13.13 chr16:10788495-10789043 (-) LTR GAGAYC - Intronic FAM18A (s) -
45 17p13.1 chr17:8056835-8057031 (+) LTRb not found - Intergenic - ALOX15B
46 17p13.1 chr17:8082291-8082848 (+) LTR CCAGG - Intronic ALOX12B (as) MIR4314
47 17q11.2 chr17:32913177-32913734 (+) LTR GGTATR - Intergenic - -
48 19p13.3 chr19:2863773-2863865 (+) LTRb not found - Intergenic - ZNF555; ZNF556
49 19p13.2 chr19:7100429-7100974 (-) LTR GTCTC - Intergenic - -
50 19p12 chr19:21987441-21988020 (+) LTR ATAAYA - Intronic ZNF208 (as) -
51 19p12 chr19:23876577-23877146 (-) LTR CTCCCC - Intergenic - -
52 19q13.11 chr19:34595165-34595718 (-) LTR TGTAGG - Intergenic - SCGBL
53 19q13.12 chr19:36636542-36637090 (-) LTR not found - Intergenic - ZNF382; ZNF461
54 19q13.2 chr19:42667555-42668111 (-) LTR GTGTG - Intergenic - -
55 19q13.31 chr19:44283216-44283766 (-) LTR GTAAG - Intergenic - ZNF233; ZNF235
56 19q13.32 chr19:46030891-46031467 (+) LTR CAAGGT - Intergenic - IGFL4; PGLYRP1
57 19q13.41 chr19:51900477-51900716 (-) LTRb not found - Intronic ZNF649 (s); ZNF619 (as) ZNF649-AS1
58 19q13.41 chr19:52460866-52466497 (-) Provirusb AAAAC - Intronic ZNF578 (as) ZNF534
59 21q22.3 chr21:43698519-43699073 (+) LTR TTTAG - Intergenic - RRP1B
60 21q22.3 chr21:43738447-43739417 (+) LTR CTAAT AluSx; AluY Intronic PDXK (as) -
61 22q11.21 chr22:20818927-20819480 (-) LTR TAAGA - Intronic PI4KA (s) -
62 22q13.31 chr22:45188740-45189285 (+) LTR TGCAAC - Intergenic - NUP50; KIAA0930
63 Xp11.23 chrX:48047190-48047228 (-) LTRb not found - Intergenic - ZNF630-AS1
64 Xp11.22 chrX:51636506-51637062 (+) LTR GCTCTA - Intergenic - -
65 Xq22.2 chrX:103469871-103470407 (-) LTR GRGGAG - Intergenic – –
66 Xq22.3 chrX:107232277-107232369 (-) LTRb not found - Intronic PIH1D3 (as) -
67 Xq27.1 chrX:139517757-139518302 (+) LTR CTTAAG - Intergenic - -
68 Yq11.221 chrY:12993871-13001093 (-) Provirus TGSATT AluY; LTR2B Intergenic - -
69 Yq11.221 chrY:13333756-13334302 (+) LTR CRYAGC - Intronic UTY (as) -
70 Yq11.221 chrY:16492757-16493302 (+) LTR TCCAAR - Intergenic - -
Chromosome bands and coordinates are according to the hg38 assembly [1] and RepeatMasker annotation [70]
As, antisense orientation; s, sense orientation; TSD, target site duplication; adenotes a tandemly repeated LTR; bdenotes truncated elements.
Ambiguous nucleotides are indicated as follows: K, G or T; M, A or C; S, C or G; R, A or G; W, A or T; Y, C or T
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Contrarily, reverse oriented proviruses may even be bene-
ficial by protecting from newly infecting retroviruses by
antisense RNA mechanisms [19] and by contributing
regulatory elements such as LTR promoters that can
modulate gene expression in cis, as shown before [7, 14].
HML-10 exerts differential LTR promoter activity in tumor
cell lines
To further investigate the potential of HML-10 in gener-
ating cis-regulatory transcripts, we determined LTR pro-
moter activities of three complete proviruses located in
reverse orientation within introns of host genes (Fig. 3).
These were elements nos. 3, 22 and 25, within the
DAP3, C4 and PKIB (Protein kinase inhibitor beta)
genes, respectively (Table 1). The PKIB gene harbors nu-
merous other intronic HERV sequences not belonging to
the HML-10 family that together with other REs consti-
tute over 50% of its genomic sequence. Three additional
HML-10 proviruses are located outside of genes, ele-
ments nos. 1, 20 and 68, and one found in an intron of
the zinc finger protein gene ZNF578, no. 58, lacks the 5′
LTR. We focused on the three complete and intronic
proviruses, referred to as HML-10(DAP3), HML-10(C4)
and HML-10(PKIB), that comprise six LTRs for pro-
moter analysis, since these could potentially generate
cis-regulatory transcripts. We preferred proviruses over
Fig. 2 Neighbor-joining tree of 68 complete HML-10 LTRs in the human genome. HML-10 LTR sequences (see Table 1) were retrieved from the
human genome GRCh38/hg38 assembly [1] according to RepeatMasker [70] annotation. The horizontal bar represents 0.1 substitutions per
nucleotide position
Broecker et al. Mobile DNA  (2016) 7:25 Page 6 of 17
solitary LTRs since proviral LTRs of the related HML-2
and HERV-W families have been shown to be stronger
promoters than the respective solitary LTRs [8, 15]. We
also found that the two LTRs of each HML-10 provirus
clustered in the neighbor-joining tree (Fig. 2). Thus, des-
pite their high sequence similarities these LTRs have
resisted homologous recombination, suggesting their
functional importance. HML-10 provirus RNA has been
detected in various human tissues and cell lines by
microarray analyses [22–27, 40–43] that, however, lack
the information whether transcription is initiated in the
5′LTR or upstream of the provirus.
To assess their promoter activities, we cloned the LTRs
of HML-10(DAP3), HML-10(C4) and HML-10(PKIB) into
the promoter-free pGL3-Enhancer luciferase reporter
vector, as described [19] (Fig. 4a). As HERV LTRs can be
bidirectional promoters [5, 17, 44], we also included the
retroviral antisense orientation for each of the six LTRs.
LTR promoter activity of HML-10(C4) has been demon-
strated before with reporter assays in the human hepatocel-
lular carcinoma cell line HepG2 and in COS7 monkey
kidney cells [19]. Additionally, HML-10 pol transcripts have
been identified in human hepatocellular carcinoma cells
and in human embryonic kidney HEK293 cells by micro-
array analysis [26] (Table 2). Based on these findings, we
transfected our pGL3-Enhancer constructs into HepG2
and HEK293T cells (HEK293 expressing SV40 virus T-
antigen) to measure their promoter activities (Fig. 4b). The
pGL3-Control vector bearing the SV40 promoter served as
positive control and empty, promoter-free pGL3-Enhancer
as negative control. HML-10(C4) showed significant tran-
scriptional activity exclusively in the 3′LTR in HepG2 in
both retroviral sense and antisense orientations. This is in
accordance with a previous study that has demonstrated
promoter activity in the 3′LTR, but not in the 5′LTR of this
provirus in the same cell line [19]. In HEK293T, we found
transcription from the 5′LTR in retroviral sense orientation
and from the 3′LTR in retroviral antisense orientation.
HML-10(DAP3) exerted bidirectional promoter activity in
its 5′LTR in both cell lines, whereas HML-10(PKIB)
showed bidirectional promoter activity in its 3′LTR, but in
HEK293T only. Therefore, all three investigated proviruses
showed transcriptional activity in at least one of their LTRs,
with cell type-specific strength and orientation (Fig. 4b).
While LTR promoter activity in retroviral antisense orienta-
tion was unlikely to primarily affect gene regulation, all
three HERVs exerted promoter activity in retroviral sense
orientation in one of their LTRs, which is antisense relative
to the respective encompassing gene. Thus, the proviruses
have the potential for antisense-mediated regulation of the
encompassing DAP3, C4 and PKIB genes in cis in a cell
type-specific manner.
Promoter activity of the HML-10(C4) 3′LTR has been
reported previously to be suppressed by IFNγ in HepG2
[19], which we reproduced (Fig. 4c). Likewise, the 5′LTR
promoter of HML-10(DAP3) in retroviral sense orienta-
tion (antisense relative to the DAP3 gene) was dose-
dependently suppressed by IFNγ. We speculate this to
be mediated by an IFNγ activated site (GAS) matching
the consensus motif 5′-TTNCNNNAA-3′, a putative
binding site for STAT1 homodimers that form during
IFNγ signaling [45]. This motif is present in all analyzed
LTRs (Fig. 4d) as well as the SV40 promoter (data not
shown). The latter is known to be inhibited by IFNγ [46]
and served as positive control for IFNγ-mediated sup-
pression (Fig. 4c). In contrast, the herpes simplex virus
Fig. 3 Genomic organization of the HML-10(DAP3), HML-10(C4) and HML-10(PKIB) proviruses (from top to bottom). The grey rectangles in the LTR
(RepeatMasker) track shows all annotated HERV elements including the indicated HML-10 proviruses. Images were retrieved and modified from
the UCSC Genome Browser [68]
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Table 2 Detection of HML-10(DAP3) pol transcripts by previously reported microarray studies [79]
Tissue/cell type HML-10(DAP3) RNA expressed HML-10(DAP3) RNA not expressed HML-10(DAP3) RNA
variably expressed
Normal tissue and non-tumor
cell lines (n = 23)
Cervix [22], epidermal keratinocytes
(HaCaT) [26], thyroid [22], umbilical
vein endothelial cells (HUVEC) [40],
uterus [22] (5/23)
Blood [22, 23], breast [25], colon [22],
heart [22], liver [22], lung [22], mamma
[22, 23], neural stem cells (HNSC.100)
[40], ovary [22], placenta [22], prostate
[22], rectum [22], skeletal muscle [22],
stomach [22], testes [22] (15/23)
Brain [22, 24], kidney
[22, 27], skin
[22, 41] (3/23)
Primary tumors and tumor
cell lines (n = 13)
CAKI (renal carcinoma) [26], GliNS1
(neural tumor stem line) [40], HEK293
(embryonic kidney) [26], HeLa
(cervix adenocarcinoma) [26], HuH-7
(hepatocellular carcinoma) [26],
MIA PaCa-2 (pancreatic carcinoma)
[26], SK-N-MC (neuroblastoma) [42, 43],
SK-N-SH (neuroblastoma) [42], T47D
(ductal breast epithelial carcinoma) [26],
U-251MG (glioblastoma) [42] (10/13)









Fig. 4 Promoter activities of HML-10 LTRs. a LTRs of the HML-10(DAP3), HML-10(C4) and HML-10(PKIB) proviruses were cloned in both orientations into
the promoter-free pGL3-Enhancer vector and transfected into HepG2 or HEK293T cells. Firefly luciferase (fLuc) activities were determined 24 h after
transfection b Promoter activities expressed as fLuc activity normalized to renilla luciferase (rLuc) activity of the co-transfected pGL4.74 vector in the
indicated cell lines. The pGL3-Control vector bearing the SV40 promoter (grey bars) served as positive and empty pGL3-Enhancer (white bars) as
negative control. Promoter activities were normalized to pGL3-Control set to 100%. The bars show mean ± SEM of three independent experiments in
duplicates. *P-value≤ 0.05, Student’s t-Test compared to pGL3-Enhancer. c For HepG2 cells the effect of IFNγ stimulation on two selected LTRs as well
as the SV40 and HSV-TK promoters is shown. LTR and SV40 activity is expressed as fLuc normalized to rLuc signals, HSV-TK activity is expressed as rLuc
activity only. The bars show mean ± SEM of at least three independent experiments and were normalized to unstimulated (-) cells set to 100%. n.d.,
not determined. d Identification of a conserved IFNγ activated site (GAS) of the consensus sequence 5′-TTNCNNNAA-3′ [45]. e Locations of primers
used to detect transcripts originating from the 5′LTR of HML-10(DAP3). The predicted TSS was identified as described in the text and Additional file 1:
Figure S1. f Detection of DAP3 mRNA and HML-10(DAP3) transcripts in HepG2 and HeLa cells by qRT-PCR. cDNA samples prepared without reverse
transcriptase (RT) for the indicated primer pairs, but with RT for GAPDH, served as controls. Values are normalized to GAPDH mRNA levels. Bars show
mean ± SD of two measurements. In most cases, the SD is too small to be visible
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thymidine kinase (HSV-TK) promoter that was used to
normalize promoter activities was unaffected by IFNγ
(Fig. 4c). The GAS motif is highly conserved among pro-
viral HML-10 LTRs in the human genome (Fig. 4d) and
the solitary LTRs (data not shown), which supports its
functional relevance. Hence, IFNγ-mediated promoter
suppression is likely a general feature of HML-10 LTRs,
in line with the known antiviral activity of interferons
[19]. This is of particular interest for possible HML-10-
mediated negative regulation of the encompassing genes,
since mRNA expression of C4 and DAP3 is known to be
induced by IFNγ [20, 47] and DAP3 is implicated in
IFNγ-dependent apoptosis [20].
Based on our promoter activity studies, HML-10(DAP3)
was the most interesting candidate for further investiga-
tion, since its 5′LTR is the only one investigated that pro-
moted transcription in the retroviral sense orientation,
which is antisense to DAP3, in both cell lines (Fig. 4b).
The involvement of an HML-10(DAP3)-primed transcript
in regulating the encompassing gene is suggested by the
fact that DAP3 expression is induced [20], whereas the
LTR promoter is suppressed by IFNγ (Fig. 4c). In addition,
HML-10(DAP3) RNA has been detected previously in
various human cancer-derived cell lines but not in most
healthy tissues (Table 2). This indicates a possible role in
the regulation of DAP3 gene expression in cancer cells
and some distinct tissues, including cervix, thyroid and
uterus as well as epidermal keratinocytes and umbilical
vein endothelial cells. Our promoter activity studies
indicated that transcription of HML-10(DAP3) originated
from the 5′LTR (Fig. 4b). For further proof, we deter-
mined the most likely TSS within this promoter. Since
LTR-dependent transcription relies on host RNA polymer-
ase (RNA pol) II [5, 48] we sought to identify the two
integral core elements of this promoter, Initiator (Inr)
elements and TATA boxes [49]. The TSS within LTRs of
the related HML-2 family has been identified previously
within an Inr element with a TATA box about 10 bp
upstream of the Inr [50]. We identified a similar configur-
ation a single time in the HML-10(DAP3) 5′LTR in retro-
viral sense orientation, an Inr element 11 bp downstream
of a TATA box (Additional file 3: Figure S2). This Inr se-
quence contained the most likely TSS. We also identified
a downstream promoter element (DPE) matching the con-
sensus 5′-RGWYVT-3′ sequence [49], a putative binding
site for the transcription factor TFIID of the RNA pol II
core promoter, at nucleotide position +19 relative to the
putative TSS. To get experimental proof that HML-
10(DAP3) transcription is initiated within this putative
TSS, we performed quantitative real-time PCR (qRT-PCR)
measurements in HepG2 cells with a reverse primer
located downstream of the TSS (LTRrev) and two different
forward primers, one located upstream (LTRfor1) and one
downstream (LTRfor2) of the TSS (Fig. 4e and Additional
file 3: Figure S2). If transcription was initiated from the
TSS, we would expect higher expression measured using
LTRfor2 + LTRrev than with LTRfor1 + LTRrev primer
combinations. This was indeed the case, whereby weak
signals seen with LTRfor1 + LTRrev likely resulted from
amplification of the intron of the DAP3 pre-mRNA
(Fig. 4f). To avoid false signals from genomic DNA for
these lowly abundant transcripts, we subjected the RNA
preparations to DNase treatment prior to reverse tran-
scription and included control samples without reverse
transcriptase that did not result in detectable amplifica-
tion. We thus verified expression of the HML-10(DAP3)
RNA that is present at about 40-fold lower levels than the
DAP3 mRNA, and provide further evidence that it origi-
nates from the 5′LTR around the predicted TSS. These
findings confirmed the weak but significant transcription
of this LTR in the promoter activity studies in retroviral
sense orientation in the same cell line (Fig. 4b). Our find-
ings are in agreement with reported microarray data that
demonstrated expression of the retroviral transcript in
various cell lines, which extends into the pol gene of the
HML-10(DAP3) provirus (Table 2). However, although
the primer combinations were designed to only amplify
the HML-10(DAP3) sequence, as judged by in silico PCR
analysis, we cannot completely rule out that transcripts of
other potentially active HML-10 elements were co-
amplified.
The pro-apoptotic effect of DAP3 has been described
previously in HeLa cells [20] in which HML-10(DAP3)
RNA has been identified by microarray analysis (Table 2).
Accordingly, we detected HML-10-primed transcripts by
qRT-PCR in HeLa where it was present at comparable
levels as in HepG2 (Fig. 4f ). We therefore selected HeLa
cells to determine the functional relevance of HML-
10(DAP3) RNA on the expression of DAP3.
Inactivation of HML-10(DAP3) RNA induces DAP3
expression and apoptosis in HeLa cells
Having confirmed the presence of HML-10(DAP3) RNA
in HeLa cells and its likely origin within the proviral 5′
LTR, we sought to determine its function within the cell.
We expected the retroviral RNA to suppress DAP3 gene
expression in cis similar to the previously described
LTR-primed regulatory transcripts [7, 14]. To determine
its potential regulatory function we aimed at inactivating
the retroviral RNA by means of sequence-specific ASOs.
We opted for ASOs rather than siRNAs that are both
known to be active in the nucleus [51, 52], the common
site of action of LTR-primed transcripts [5], as siRNAs
may directly influence DAP3 expression levels through
the passenger strand that would be antisense to the
DAP3 pre-mRNA. ASO-mediated inactivation of the
HML-10(DAP3) RNA was expected to activate DAP3
gene expression.
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We designed four ASOs downstream of the putative
TSS, ASOs 1–4, to counteract the retroviral RNA
(Fig. 5a). At 24 h after transfecting the ASOs at 25 or 50
nM into HeLa cells, we determined HML-10(DAP3) and
DAP3 expression at the RNA level by qRT-PCR. Trans-
fecting the ASOs caused an increase in DAP3 mRNA
levels, as expected, but not a decrease in HML-10(DAP3)
RNA (Fig. 5b). These observations likely indicate that the
ASOs blocked association of DAP3 pre-mRNA with the
retroviral RNA, but did not significantly mediate cleavage
of the latter. Although RNase H1/H2-dependent hybrid-
specific RNA degradation has been reported to be induced
by ASOs [51, 53], cleavage efficiency is largely sequence-
dependent and the HML-10(DAP3) RNA might resist
degradation. For these reasons, measuring DAP3 mRNA
levels was the only feasible way to assess the impact of
inactivating the retroviral RNA. Transfecting ASOs 1–4
resulted in increased DAP3 mRNA levels with varying effi-
ciencies (Fig. 5b). When used at 25 nM, ASOs 1–4
increased DAP3 mRNA levels about 5-fold as compared
to non-transfected control cells. The most efficient ASO 2
exerted a dose-dependent increase of the DAP3 mRNA
up to 10-fold at 50 nM. Both control ASOs, one with a
random sequence (Mock) and one immediately upstream
of the 5′LTR, did not significantly change DAP3 expres-
sion levels, demonstrating a sequence-dependent effect
and that the HML-10(DAP3) RNA originates from the 5′
LTR. Although ASOs 1–4 were designed to only map to
the DAP3 locus, we consider the possibility that HML-10
RNA species transcribed at other loci that may act in trans
on DAP3 expression may have been inactivated by these
ASOs as well. Overall, the use of ASOs to counteract
HML-10-primed transcripts confirmed their negative
impact on DAP3 mRNA expression levels.
DAP3 is an adapter protein that links the intracellular
portion of DRs to the Fas-Associated Death Domain
(FADD) in the DR pathway of extrinsic apoptosis [21].
Consequently, we expected the HML-10(DAP3) RNA to
suppress apoptosis via this pathway. Overexpressing
DAP3 has been shown to induce apoptosis in HeLa cells
[20]. We wondered whether upregulation of DAP3 by
the most effective ASO 2 at 50 nM (Fig. 5b) was
Fig. 5 Inactivating the HML-10(DAP3) RNA induces DAP3 expression and apoptosis in HeLa cells. a Target regions of sequence-specific ASOs are
indicated. ASOs 1-4 are in antisense orientation to the retroviral transcript and in sense orientation to the DAP3 transcript. The ASO designated as
Upstream served as control. b Cells were transfected with 25 or 50 nM of the indicated ASOs. At 24 h after transfection, expression levels of HML-10(DAP3)
(left) and DAP3 mRNA (right) were determined by qRT-PCR. Bars show mean ± SEM of three independent experiments. RNA levels were normalized to
GAPDH and levels of non-transfected cells were set to 1. *P-value≤ 0.05, Student’s t-Test against Mock. c Cells were transfected with the indicated ASOs at
50 nM, after 24 h stimulated with 1000 U/mL IFNγ or 100 ng/mL TNFα, or left unstimulated. After additional 24 h, Trypan Blue exclusion as indicator of dead
cells (left), MTS cell viability assays (center) or light microscopic analysis (right) was performed. Bars show mean ± SEM of three independent experiments
in duplicates. *P-value≤ 0.05, Student’s t-Test. The scale bar in light microscopy panel 1 is 100 μm. d Cells were transfected with the indicated ASOs at
50 nM. At 48 h after transfection, genomic DNA of these cells was prepared with the Apoptotic DNA Ladder Kit (Roche). The control DNA is from apoptotic
U937 cells provided with the kit
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sufficient to cause apoptosis. To this end, we compared
the effect of ASO 2 with known apoptosis-inducing
stimuli, tumor necrosis factor-alpha (TNFα) and IFNγ,
on HeLa cells. Both cytokines significantly induced cell
death associated with diminished cell viability, as well as
cell rounding characteristic of apoptosis (Fig. 5c). Like-
wise, HeLa cells transfected with ASO 2 showed similar
signs of apoptosis but not those transfected with Mock
ASO. The fraction of dead cells was significantly higher
for ASO 2-transfected cells when compared to Mock-
transfected cells (24.8% vs. 8.0%, P = 10−4), and cell viability
was lower (47.9% vs. 76.8% relative to non-transfected cells,
P = 10−4). In addition, transfection of ASO 2, but not of
Mock, induced features of apoptosis, such as detachment
from the tissue culture dish, rounding and shrinking
(Fig. 5c, light microscopy panels 1 and 2). This was
supported by another test for apoptosis, genomic DNA
fragmentation, that occurred upon transfection of ASO 2
(Fig. 5d). These findings provided evidence that ASO 2-
mediated induction of DAP3 mRNA led to increased ex-
pression of DAP3 protein that is required for apoptosis and
DNA fragmentation. Thus, inactivating HML-10(DAP3)
RNA increased DAP3 expression sufficiently to induce
apoptosis, which demonstrates the functional relevance of
this retroviral transcript.
In parallel, we assessed whether inactivating HML-
10(DAP3) RNA also increased the susceptibility to apop-
tosis by TNFα. We expected this since TNFα stimulates
extrinsic apoptosis via the DR pathway that involves
DAP3 [21]. Thus, inactivation of HML-10(DAP3) RNA
with resulting DAP3 overexpression and TNFα stimula-
tion may promote apoptosis synergistically. Indeed, ASO
2-transfected HeLa cells that were additionally stimulated
with TNFα exhibited increased signs of apoptosis com-
pared to unstimulated ASO 2-transfected cells (Fig. 5c,
light microscopy panels 2 and 6), and contained a larger
fraction of dead cells (38.1% vs. 24.8%), albeit without
statistical significance (Fig. 5c). Stimulating ASO 2-
transfected cells with IFNγ had less pronounced ef-
fects on the fraction of dead cells and viability (Fig. 5c),
which may be because IFNγ induces apoptosis inde-
pendent of DR signaling. Conclusively, we showed that
DAP3 expression is negatively regulated by the HML-
10(DAP3) RNA to an extent that apoptosis is inhibited
in HeLa cells.
Discussion
Here we have characterized the previously little described
HML-10 family of endogenous retroviruses in the human
genome and studied its potential in regulating host gene
expression. We found that the infectious progenitor of
HML-10 invaded the ancestral genome of OWMs about
35 Mya (Fig. 1b). With 70 identified elements, HML-10 is
a relatively small HERV family when compared, for
instance, to the intensely investigated HML-2 that consti-
tutes about 2500 sequences in the human genome [4]. It
is known that HERVs, after de novo integration, may in-
crease in number due to chromosomal duplication events
[4]. However, sequence comparisons of the TSDs (Table 1)
and the flanking regions (Additional file 1: Figure S1) indi-
cated that only one of the 70 identified HML-10 elements
is the result of a chromosomal duplication, whereas the
other 69 elements most likely arose by independent retro-
viral integrations. We found an unusually high abundance
of HML-10 within introns of host genes when compared
to other HERV sequences including those of phylogenetic-
ally related HML families (Fig. 1e), indicating that this
family in particular has been evolutionary co-opted for
gene regulatory functions. Since LTR promoter activity of
the provirus in the C4 gene has been demonstrated previ-
ously [19], we hypothesized HML-10 to express LTR-
primed regulatory transcripts in cis similar to recently re-
ported HML-2 [14] and HERV-E [7] LTRs.
To assess their potential in expressing such regulatory
RNAs, LTRs of three selected, intron-located HML-10
proviruses were subjected to promoter activity studies in
HepG2 and HEK293T cells (Fig. 4b). Interestingly, both
strength and orientation of LTR transcription differed
substantially between the cell lines. Based on the pro-
moter activity studies, all three investigated HML-10
proviruses had the potential to negatively regulate their
encompassing genes by priming antisense RNAs. The
HML-10(DAP3) provirus located in the DAP3 gene
showed LTR promoter activity in retroviral sense orien-
tation (antisense relative to DAP3) in both cell lines and
was therefore selected for further analysis (Fig. 4b).
DAP3 is a signaling protein involved in the DR pathway
of extrinsic apoptosis that induces apoptosis when over-
expressed [20, 21]. Promoter activity of the HML-
10(DAP3) 5′LTR in retroviral sense orientation (anti-
sense relative to the DAP3 gene) was suppressed by
IFNγ, as reported previously for the HML-10 provirus in
the C4 gene [19] (Fig. 4c). This might, at least partially,
explain how DAP3 gene expression is induced by IFNγ
[20]. In HeLa cells, we found that counteracting the
retroviral transcript by sequence-specific ASOs led to an
increase of DAP3 expression levels sufficient to induce
apoptosis (Fig. 5b,c). Two control ASOs, one targeting a
region upstream of and one with a randomized se-
quence, did neither induce DAP3 mRNA expression nor
apoptosis, verifying that the ASO transfection procedure
itself did not exert any non-specific effects on these two
read-outs. Thus, the HML-10(DAP3) RNA suppressed
apoptosis in HeLa. HML-10 transcripts originating from
other loci may have been inactivated by the ASOs as
well and consequently might also contribute to the reduc-
tion of DAP3 expression in trans. ASO-mediated inactiva-
tion confirmed that the HML-10-primed transcripts,
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despite being about 60-fold weaker expressed than the
DAP3 mRNA in this cell line (Fig. 4f), had a substantial
impact on DAP3 expression levels. Indeed, regulatory
non-coding RNAs are often weakly expressed [54] and
capable of substantially down-regulating gene expression
even if 10-100 fold less abundant than their respective
mRNA [55]. Among the mechanisms that have been pro-
posed for this kind of gene regulation is the induction of
repressive epigenetic modifications that lead to hetero-
chromatin formation, or transcriptional collision of oppos-
ing RNA polymerases [54]. It has been shown previously
that preventing association between weakly expressed
regulatory RNAs and their corresponding mRNA (as op-
posed to degradation of the regulatory RNA) is sufficient
to substantially induce mRNA expression [55], which
might explain why we did not observe ASO-mediated
degradation of HML-10 RNA but nevertheless an increase
in DAP3 mRNA expression levels (Fig. 5b).
Promoter activity studies (Fig. 4b), qRT-PCR experi-
ments (Fig. 4f ), and the fact that the ASO immediately
upstream of the LTR did not affect DAP3 expression
levels (Fig. 5b) provided evidence that the retroviral
RNA originates from the proviral 5′LTR. We determined
the most likely TSS within this LTR by in silico sequence
analysis (Additional file 3: Figure S2). Attempts to experi-
mentally verify this TSS by 5′RACE-PCR as described
previously [14] were not successful, as orientation-specific
cDNA synthesis did not yield sufficient starting material
for subsequent PCR reactions (see Methods section for
details). Insufficient orientation-specific cDNA synthesis
may have been due to the low abundance of the HML-
10(DAP3) RNA as seen by qRT-PCR (Fig. 4f) and is a
known issue with rare transcripts [56]. Thus, the actual
TSS of the retroviral transcript may differ from the pre-
dicted one but our experiments provide evidence that it is
located between the target regions of ASO upstream and
ASO 1 (Fig. 5a). Our findings indirectly confirmed the
expression of HML-10(DAP3) RNA in HeLa cells, which
was supported by reported microarray experiments
(Table 2). Further direct proof could be obtained by se-
quencing cDNA clones and identifying genomic markers
that are unique to the HML-10(DAP3) copy, such as the
AluSp or MER11B repeats that are integrated into this
provirus (Table 1).
Suppression of apoptosis, as mediated by the HML-
10(DAP3) RNA in HeLa cells, is a general hallmark of
cancer cells [57]. Thus, retroviral transcripts may con-
tribute to the malignant cellular phenotype of this cell
line by counteracting DAP3 expression, and thereby sup-
pressing apoptosis. Aberrant expression levels of DAP3
have been suggested to play a role in some cases of ma-
lignant disease [58–63]. The data shown here indicate
that most of the HML-10 LTRs are even weaker
expressed than the one analyzed. We hypothesize that
the LTRs, which are normally strong promoters in infec-
tious retroviruses, have been silenced by mutation dur-
ing evolution. Thus, they likely play a limited role in
cancer promotion.
The data presented in Fig. 4b-c suggests that the ex-
pression of LTR-primed transcripts varies substantially
in intensity and direction depending on the cell type as
well as the action of cytokines. Moreover, despite its
weak expression at about 60-fold lower levels than
DAP3 mRNA (Fig. 4f ) the HML-10-primed RNA had a
strong impact on DAP3 gene regulation (Fig. 5b). Con-
sistent contributions of this and other HERV-primed
RNAs to various tissues or tumors may therefore be
hard to identify. However, the presence of HML-
10(DAP3) RNA in many tumor cell lines and the ab-
sence in most healthy tissues (Table 2) suggest that its
upregulation may be a relevant feature in some human
cancer diseases. This is in line with the observation that
transcriptional activation of HERVs and other REs by
epigenetic DNA demethylation is a frequent characteris-
tic of malignant cells [64–66].
Conclusions
This work provides experimental support for recent evi-
dence that HERVs and other REs play a role in gene
regulation and cellular processes relevant to mammalian
tumor cell formation. In the case presented here, tran-
scripts of the previously little described HML-10 family
suppressed the pro-apoptotic DAP3 gene and conse-
quently, apoptosis in HeLa cells. Therefore, we could
verify a direct link between HERV expression and cellu-
lar phenotype in this cell line. A potential role of these
LTRs in promoting a malignant phenotype possibly by
inducing resistance to apoptosis as described here in
other cell lines or tissues requires further investigation.
Methods
Identification of HML-10 elements in the human genome
The Table Browser function [67] of the UCSC Genome
Browser [68] was used to identify HML-10 elements in
the human genome. We queried the Repbase sequence
of HML-10 LTRs, LTR14 [69], in the RepeatMasker
track [70] of the GRCh38/hg38 human genome assembly
[1]. This search yielded 86 hits. Manual inspection of
these hits revealed the 70 unique HML-10 elements
listed in Table 1.
Estimation of the evolutionary age of HML-10 proviruses
For each of the six complete HML-10 proviruses (ele-
ments Nos. 1, 3, 20, 22, 25 and 68 in Table 1), both LTR
sequences (5′ and 3′LTRs) were aligned with Clustal X
2.0 [71]. The evolutionary age of each provirus was
calculated from the number of mutations between both
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LTRs by applying an estimated nucleotide substitution
rate of 2.28 per site and year × 10−9 as described [28].
Construction of phylogenetic neighbor-joining trees
The pol sequences of HML-10 and other betaretroviruses
were retrieved from published literature [18, 72]. The fasta
protein sequences can be found in Additional file 4. Se-
quences were aligned with Clustal X 2.0 [71] using stand-
ard parameters of the Multiple Alignment Mode. The
neighbor-joining tree was visualized with TreeView 1.6.6
[73]. The phylogenetic tree of HML-10 LTR nucleotide se-
quences and those of the flanking sequences shown in
Additional file 1: Figure S1 were constructed similarly. All
nucleotide sequences were retrieved from the UCSC Gen-
ome Browser [68] and the current release of the human
genome, GRCh38/hg38 [1].
Identification of target site duplications
The sequences immediately up- and downstream of
RepeatMasker-annotated HML-10 elements (Table 1)
were searched for homologous sequences in the retro-
viral sense orientation. Homologous sequences of at
least 5 bp were defined as TSDs, allowing for one (5 bp
TSDs) or two (6 bp TSDs) nucleotide mismatches.
Location of HERV sequences relative to human genes
The fractions of intragenic HERV sequences were deter-
mined with the UCSC Table Browser [67] using the
GRCh38/hg38 human genome assembly [1]. HERV ele-
ments were identified as described below in this paragraph
within the RepeatMasker track [70]. The output of these
searches was used to generate custom tracks covering the
sequences of the respective HERV families. Using the inter-
section function, the overlap of HERV sequences with a
custom track representing full-length RefSeq genes was de-
termined, yielding the following values (displayed as:
HERV family, Repbase annotation, sequence covered, se-
quence intersected with RefSeq genes): HML-1, LTR14A /
LTR14B / LTR14C, 274,910 bp, 66,940 bp (24.35%); HML-
2, LTR5A / LTR5B, 595,281 bp, 171,219 bp (28.76%);
HML-3, MER9B / MER9a1 / MER9a2 / MER9a3,
568,179 bp, 151,429 bp (26.65%); HML-4, LTR13 / LTR13A,
545,702 bp, 200,556 bp (26.75%); HML-5, LTR22 / LTR22A
/ LTR22B / LTR22B1 / LTR22B2 / LTR22C / LTR22C0 /
LTR22C2 / LTR22E, 396,533 bp, 105,855 bp (26.70%);
HML-6, LTR3 / LTR3A / LTR3B, 130,701 bp, 37,058 bp
(28.35%); HML-7, MER11D, 194,536 bp, 60,756 bp
(31.23%); HML-8, MER11A / MER11B / MER11C,
2,222,448 bp, 656,281 bp (29.53%); HML-10, LTR14,
40,556 bp, 19,443 bp (47.94%); HERV-W, LTR17,
482,257 bp, 134,803 bp (27.95%). All RepeatMasker-
annotated HERV elements covered 266,970,452 bp,
of which 75,967,800 bp (28.46%) intersected with
RefSeq genes. The fraction of the total genome
(3,088,269,808 bp) accounted for RefSeq genes was
1,320,982,363 bp (44.97%).
Cell lines and culture conditions
HeLa (ATCC CCL-2), HepG2 (ATCC HB-8065) and
HEK293T cell lines were cultivated in complete growth
medium; Dulbecco’s Modified Eagle’s Medium (DMEM)
(Invitrogen, Carlsbad, CA, USA) supplemented with 10%
heat-inactivated fetal calf serum (Invitrogen) and 100 U/
mL penicillin, 100 μg/mL streptomycin and 0.25 μg/mL
amphotericin (Antibiotic-Antimycotic by Invitrogen).
Cells were incubated at 37 °C with 5% CO2. Subcultiva-
tion ratios ranged between 1:2 and 1:10.
Primers
All primers were synthesized by Microsynth AG, Balgach,
Switzerland. Primer sequences are listed in Additional file
5. Primer sequences were designed such that they only
amplified the desired regions, as verified by the in silico
PCR analysis tool of UCSC on https://genome.ucsc.edu/
cgi-bin/hgPcr/.
Construction of pGL3-Enhancer luciferase reporter vectors
LTRs of HML-10(C4), HML-10(DAP3) and HML-10(PKIB)
were amplified by standard PCR from genomic DNA of the
QBL cell line (No. 4070713) obtained from the Health Pro-
tection Agency Culture Collections (ECACC, Salisbury,
UK), using primer pairs with a HindIII or XhoI cleavage site
at their 5′ ends. HML-10(C4) primer pairs: 5′LTR(s),
C4_5LTRforHindIII +C4_5LTRrevXhoI; 5′LTR(as), C4_5L
TRforXhoI +C4_5LTRrevHindIII; 3′LTR(s), C4_3LTRforHin
dIII+C4_3LTRrevXhoI; 3′LTR(as), C4_3LTRforXhoI +C4_3
LTRrevHindIII. HML-10(DAP3) primer pairs: 5′LTR(s),
DAP3_5LTRforHindIII +DAP3_5LTRrevXhoI; 5′LTR(as), D
AP3_5LTRforXhoI +DAP3_5LTRrevHindIII; 3′LTR(s), DA
P3_3LTRforHindIII +DAP3_3LTRrevXhoI; 3′LTR(as), DAP
3_3LTRforXhoI +DAP3_3LTRrevHindIII. HML-10(PKIB)
primer pairs: 5′LTR(s), PKIB_5LTRforHindIII + PKIB_5
LTRrevXhoI; 5′LTR(as), PKIB_5LTRforXhoI + PKIB_5LTR-
revHindIII; 3′LTR(s), PKIB_3LTRforHindIII + PKIB_3LTR-
revXhoI; 3′LTR(as), PKIB_3LTRforXhoI + PKIB_3LTRrev
HindIII). Cycling conditions were 10 min. 95 °C; (30 s. 95 °
C, 30 s. 60 °C, 30 s. 72 °C) × 40; 7 min. 72 °C. LTRs were
cloned into the pGL3-Enhancer vector (Promega, Madison,
WI, USA), containing the fLuc gene as reporter, after
digestion with HindIII and XhoI (New England Biolabs,
Ipswich, MA, USA) and phosphatase treatment. Vectors
were ligated with T4 DNA Ligase (New England Biolabs).
All vector constructs were heat-shock-transformed into
competent E. coli JM109 (Promega). Positive colonies were
detected by ampicillin resistance on selective agar plates.
Selected clones were grown in ampicillin-containing LB
medium and plasmid DNA was isolated with the QIAamp
Plasmid DNA Mini Kit (Qiagen, Hilden, Germany).
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Plasmid DNAs were screened for correct inserts by restric-
tion enzyme digestions using appropriate enzyme combina-
tions and subsequent agarose gel electrophoresis as well as
by capillary sequencing (Microsynth, Balgach, Switzerland).
Determination of LTR promoter activities
Freshly passaged HepG2 or HEK293T cells were seeded
into 24-well tissue culture plates (4x104 cells per well in
complete growth medium) and cultivated overnight to
~80% confluence. Cells were transfected with 50 ng/well
of pGL3-Enhancer constructs, empty pGL3-Enhancer,
or pGL3-Control, 4 ng/well of pGL4.74 vector for
normalization (Promega) and 346 ng/well of unrelated
carrier DNA using DreamFect Gold transfection
reagent (OZ Biosciences, Marseille, France) following
the manufacturer’s recommendations. Vector pGL4.74
contains the renilla luciferase (rLuc) gene under
control of the herpes simplex virus thymidine kinase
(HSV-TK) promoter. Medium was replaced with fresh pre-
warmed complete growth medium 6 h post-transfection.
At 24 h post-transfection, medium was aspirated, cells were
rinsed with prewarmed PBS, lysed, and fLuc and rLuc
activities in each sample were determined with the Dual-
Glo Luciferase Assay System (Promega) in a Sirius Lumin-
ometer (Berthold Detection Systems, Pforzheim, Germany).
fLuc activities were normalized to rLuc activities for each
sample. To assess the effect of IFNγ stimulation on pro-
moter activities, selected pGL3-Enhancer constructs were
transfected into HepG2 cells as above and were stimulated
with different amounts of recombinant human IFNγ
(PeproTech, Rocky Hill, NJ, USA) by addition to the
growth medium immediately after medium change 6 h
post-transfection. fLuc activities were determined 30 h
post-transfection.
Inactivation of HML-10(DAP3) RNA with ASOs
The ASOs were 25-mer DNA molecules with phosphoro-
thioate bonds at the flanking three nucleotides on both
sides to confer exonuclease resistance. ASOs for inactivat-
ing the HML-10(DAP3) RNA were designed to be com-
plementary to regions within the 5′LTR or the proviral
body downstream of the predicted TSS. We used only se-
quences that uniquely mapped to their respective target
region and nowhere else in the human genome. A Mock
ASO with a randomized sequence and one complemen-
tary to a region shortly upstream of the 5′LTR were used
as negative controls. ASOs were purchased from Micro-
synth. Their sequences are listed in Additional file 6.
qRT-PCR
Freshly passaged HepG2 or HeLa cells were seeded in
96-well plates (104 cells per well in complete growth
medium) and grown overnight to ~80% confluence.
Cells were transfected with 25 or 50 nM of the indicated
ASOs using DreamFect Gold transfection reagent (OZ
Biosciences) according to the manufacturer’s recommen-
dations. Medium was replaced with fresh prewarmed
complete growth medium 6 h post-transfection. At 24 h
post-transfection, total RNA was extracted using the
QIAamp RNA Blood Mini Kit (Qiagen), including an
on-column DNA digestion step with the RNase-free
DNase Set (Qiagen). First strand cDNA was synthesized
using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, Foster City, CA, USA) with
random hexamer primers. qRT-PCR was performed
using the TaqMan Universal PCR Master Mix (Applied
Biosystems) with the addition of 1:10000 (v/v) SYBR
Green I (Sigma-Aldrich, St. Louis, MO, USA) and
primers specific for DAP3 (DAP3for +DAP3rev) or
GAPDH (GAPDHfor +GAPDHrev) mRNAs, HML-
10(DAP3) RNA (LTRfor2 + LTRrev) or LTRfor1 + LTRrev
as control reaction. Cycling conditions were 2 min. 50 °
C; 10 min. 95 °C; (15 s. 95 °C, 1 min. 58 °C) × 65. Speci-
ficity of the PCR reactions was assessed by checking for
correct amplicon lengths and amplification artifacts by
agarose gel electrophoresis. All shown RNA levels were
calculated by relative quantification (double delta Ct
method) using GAPDH as reference, with primer effi-
ciencies calculated from serial dilutions of HepG2 cDNA
samples. Control samples without addition of reverse
transcriptase gave no amplification signals.
Strand-specific cDNA synthesis
A number of 106 freshly passaged HepG2 or HeLa cells
were seeded into wells of 6-well plates and grown over-
night to ~80% confluence. Total RNA was extracted
using the QIAamp RNA Blood Mini Kit (Qiagen). First
strand cDNA was synthesized using either the Reverse
Transcriptase of the High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems), or the Thermoscript
Reverse Transcriptase (Invitrogen) with primers specific
for the HML-10(DAP3) transcript (Additional file 5).
Different incubation times and temperatures (ranging
from 25 to 60 °C) were evaluated. To assess reverse tran-
scription efficiencies, qRT-PCR was done using TaqMan
Universal PCR Master Mix (Applied Biosystems) with
the addition of 1:10000 (v/v) SYBR Green I (Sigma-Aldrich)
and primers LTRfor2 + LTRrev. Cycling conditions were
2 min. 50 °C; 10 min. 95 °C; (15 s. 95 °C, 1 min. 58 °C) × 65.
No specific amplification was detected, while positive con-
trols with cDNA prepared with random hexamer primers
and with genomic human DNA yielded HML-10(DAP3)-
specific amplicons.
Trypan Blue exclusion and cell viability (MTS) assays
Freshly passaged HeLa cells were seeded in 48-well plates
(2x104 cells per well in complete growth medium) and culti-
vated overnight to ~70% confluence. Cells were transfected
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with 50 nM of the indicated ASOs using the DreamFect
Gold transfection reagent (OZ Biosciences) according to the
manufacturer’s recommendations. Medium was replaced
with fresh prewarmed complete growth medium 6 h post-
transfection. At 24 h post-transfection, cells were stimulated
with 1000 U/mL recombinant human IFNγ (PeproTech) or
100 ng/mL recombinant human TNFα (Biomol, Hamburg,
Germany) for 24 h by addition to the growth medium, or
left unstimulated. For Trypan Blue exclusion assays, cells
were harvested 48 h post-transfection, resuspended in 50 μL
PBS, mixed 1:1 (v/v) with 50 μL 0.4% (v/v) Trypan Blue
Stain (Invitrogen) and incubated for 1 min. Total cell num-
ber and number of stained cells of each sample were
counted in a hemocytometer. About 100–200 total cells per
sample were counted. To obtain the fraction of dead cells,
the number of stained cells was divided by the total cell
number. For cell viability (MTS) assays, one tenth of the
growth medium volume of MTS reagent (CellTiter 96
AQueous One Solution Cell Proliferation Assay by
Promega) was added to each well 48 h post-transfection.
Cells were incubated for approximately 1 h before the
absorbance at 495 nm of the supernatants was measured
with a NanoDrop ND-1000 Spectrophotometer (Thermo
Scientific, Waltham, MA, USA). Fresh growth medium with
the addition of one tenth of MTS reagent was used as blank.
Detection of apoptosis by DNA laddering
Freshly passaged HeLa cells were seeded into 6-well
plates (106 cells per well in complete growth medium)
and cultivated overnight to ~70% confluence. Cells
were transfected with 50 nM of the indicated ASOs
using the DreamFect Gold transfection reagent (OZ
Biosciences) according to the manufacturer’s recom-
mendations. Medium was replaced with fresh prewarmed
complete growth medium 6 h post-transfection. At 48 h
post-transfection, cells were lysed and DNA was prepared
with the Apoptotic DNA Ladder Kit (Roche, Mannheim,
Germany) according to the manufacturer’s recommenda-
tions. Samples were analyzed using a 1% agarose TAE gel
and DNA was visualized with ethidium bromide.
Additional files
Additional file 1: Figure S1. (a) Neighbor-joining trees of the flanking
1000 bp upstream (left tree) and downstream (right tree) relative to retroviral
orientation. Two pairs of flanking sequences that cluster are highlighted by
colored boxes, whereby elements nos. 3 and 43 only clustered in
their upstream regions. Element numbers according to Table 1 are
shown in parentheses. The horizontal bars represent 0.1 substitutions
per nucleotide position. (b) Comparison of the genomic loci representing
HML-10 elements nos. 3 and 43 (see blue boxes in panel (a)) that integrated
into a L1MB7 repeat or into a MER4A1 repeat, respectively. Both HML-10
elements therefore likely represent independent integration events. (c)
Comparison of the genomic loci representing HML-10 elements nos. 27 and
45 (red boxes in panel (a)) that are both flanked by LTR5_Hs and HERVK-int
repeats in the same configuration. The overall sequence identity of the
depicted regions is >88%. Therefore, one of these HML-10 was likely
the result of a chromosomal duplication event that copied the other
one. Images in panels (b) and (c) were obtained from the UCSC
Genome Browser [68]. (PDF 1217 kb)
Additional file 2: Table S1. Presence or absence of HML-10 in different
mammalian genomes. The number of LTR14 hits that represent HML-10
elements in the indicated genomes were assessed with the UCSC Table
Browser [67] by querying LTR14 in the respective RepeatMasker tracks [69, 70].
BLAT [74] searches within the UCSC Genome Browser [68] using the
consensus sequence of LTR14 obtained from the DFAM database
(www.dfam.org) [75] were performed verify the presence of HML-10.
(PDF 262 kb)
Additional file 3: Figure S2. Identification of a putative TSS in the
HML-10(DAP3) 5′LTR. The sequence shown is chr1:153935293–153936036
of the human genome hg18 assembly [1]. The HML-10(DAP3) 5′LTR
(according to RepeatMasker annotation [70]) is highlighted in bold
letters. Six Inr sequences highlighted blue were identified by sequence
homology searches of the consensus YYANWYY sequence [76]. Five TATA
boxes highlighted red were identified with the TFBind program [77] on
http://tfbind.hgc.jp using a similarity threshold of 0.8. Inr2 and TATA4 are
overlapping. Only one Inr element (Inr1) is located in close proximity
downstream of a TATA box (TATA3). The putative TSS within Inr1 is
underlined. A downstream promoter element (DPE) highlighted violet
matching the consensus RGWYVT sequence [49] is located 19 bp
downstream of the putative TSS. Primer locations for LTRfor1, LTRfor2
and LTRrev (see Additional file 4) are indicated by arrows. An IFNγ
activated sequence (GAS) is highlighted green. (PDF 364 kb)
Additional file 4: Protein fasta sequences of Pol proteins of different
endogenous and exogenous betaretroviruses. (TXT 11 kb)
Additional file 5: Primer sequences. (XLS 42 kb)
Additional file 6: Sequences of ASOs. Asterisks denote
phosphorothioate bonds. (XLS 39 kb)
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